Schenkein, D.

patient bortezomib myeloma trial response sample blood therapy study survival expression analysis classi phase erasmus mc dexamethasone genomic figure number signi gene expression treatment research table high-dose millennium pharmaceuticals high-dose dexamethasone accuracy tumor myeloma cells signi ficantly article group classi fier cancer disease marrow prognostic erasmu american society j clin oncol library survival classi fier gene expression data 2012. outcome cycle analyses model protein volume probe sets dataset month fi rst response information myeloma purity score bortezomib trials blood score speci subtype level phase 3 trial factor br j haematol subset bortezomib arm dex arm plasma richardson prediction ficant april purity gene sets value control al blood bone marrow aspirate pathway